Showing results (91-100 of 469) with videos related to

Sort By:
Pageof 47
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 13, 2016
Reduced Amplitude of Low-Frequency Brain Oscillations in the Psychosis Risk Syndrome and Early Illness SchizophreniaSusanna L Fryer, Brian J Roach, Katherine Wiley, et al.
Schizophrenia Bulletin|February 1, 2018
Should I Stay or Should I Go? FMRI Study of Response Inhibition in Early Illness Schizophrenia and Risk for PsychosisSusanna L Fryer, Brian J Roach, Judith M Ford, et al.
Archives of General Psychiatry|March 7, 2007
Relationship of imprecise corollary discharge in schizophrenia to auditory hallucinationsTheda H Heinks-Maldonado, Daniel H Mathalon, John F Houde, et al.
Psychopharmacology|August 7, 2021
Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depressionSteven Pennybaker, Brian J Roach, Susanna L Fryer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 13, 2017
Response to Targeted Cognitive Training Correlates with Change in Thalamic Volume in a Randomized Trial for Early SchizophreniaIan S Ramsay, Susanna Fryer, Alison Boos, et al.
Archives of General Psychiatry|February 6, 2004
Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imagingJudith M Ford, Max Gray, Susan L Whitfield, et al.
Schizophrenia Bulletin|October 10, 2019
Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control TrialSamantha V Abram, Lize De Coster, Brian J Roach, et al.
Psychological Medicine|January 16, 2019
Parsing components of auditory predictive coding in schizophrenia using a roving standard mismatch negativity paradigmAmanda McCleery, Daniel H Mathalon, Jonathan K Wynn, et al.
Frontiers in Behavioral Neuroscience|April 11, 2022
Psychological Dimensions Relevant to Motivation and Pleasure in SchizophreniaSamantha V Abram, Lauren P Weittenhiller, Claire E Bertrand, et al.
Molecular Psychiatry|April 15, 2022
Validation of ketamine as a pharmacological model of thalamic dysconnectivity across the illness course of schizophreniaSamantha V Abram, Brian J Roach, Susanna L Fryer, et al.
Pageof 47